PPBT

Purple Biotech Ltd. (NASDAQ:PPBT) is a clinical-stage biotechnology company founded in Israel and headquartered in Rehovot. The company went public on NASDAQ in November 2015, originally operating under the name Kitov Pharma Ltd before rebranding to Purple Biotech in December 2020. Purple Biotech focuses on developing innovative cancer therapies designed to overcome tumor immune evasion, with a pipeline of experimental drugs currently in various phases of clinical trials targeting solid tumors including lung and pancreatic cancers.